PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 44 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $6,000 | -72.7% | 57,900 | 0.0% | 0.00% | – |
Q2 2016 | $22,000 | 0.0% | 57,900 | +1.0% | 0.00% | – |
Q1 2016 | $22,000 | 0.0% | 57,300 | +3.3% | 0.00% | – |
Q4 2015 | $22,000 | -31.2% | 55,450 | 0.0% | 0.00% | – |
Q3 2015 | $32,000 | +6.7% | 55,450 | 0.0% | 0.00% | – |
Q2 2015 | $30,000 | +3.4% | 55,450 | +56.4% | 0.00% | – |
Q1 2015 | $29,000 | +3.6% | 35,450 | 0.0% | 0.00% | – |
Q4 2014 | $28,000 | – | 35,450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HOME FEDERAL BANK OF TENNESSEE | 100,000 | $6,000 | 0.00% |
LEE DANNER & BASS INC | 50,000 | $3,000 | 0.00% |
Ancora Advisors LLC | 14,650 | $1,000 | 0.00% |
Diversified Trust Co | 50,000 | $3,000 | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 57,659 | $3,000 | 0.00% |
ACADEMY CAPITAL MANAGEMENT INC/TX | 20,000 | $1,000 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |